# AI_MODEL_SAFETY_CASE.md  
**Structured Safety Assurance Case for Clinical AI Models**

---

## 1. Purpose

This document defines the **AI Model Safety Case** required for any AI system operating within the NeuroGrid ecosystem.

The safety case provides a **structured, evidence-backed argument** demonstrating that an AI model is:
- Safe for its intended use
- Appropriately constrained
- Subject to effective human oversight
- Continuously monitored and governed

No AI model may be deployed, updated, or reactivated without an approved safety case.

---

## 2. Scope

This safety case applies to all AI models that:
- Consume RPM or clinical data
- Generate alerts, risk scores, or recommendations
- Influence clinical review, triage, or safety decisions

It applies across the full model lifecycle:
- Design
- Validation
- Deployment
- Operation
- Post-market monitoring
- Retirement

---

## 3. Safety Case Philosophy

NeuroGrid adopts a **Goal-Structured Safety Case** approach:

> Claims of safety must be justified.  
> Justifications must be evidenced.  
> Evidence must be auditable.

Performance alone is insufficient proof of safety.

---

## 4. Safety Objectives

Each AI model safety case must explicitly demonstrate:

- No autonomous clinical action
- Controlled and explainable outputs
- Defined failure modes
- Enforced confidence thresholds
- Human-in-the-loop governance
- Safe degradation under uncertainty

Objectives are non-negotiable.

---

## 5. Intended Use Definition

The safety case must clearly state:
- Intended clinical context
- Supported decision types
- User roles (e.g., clinician reviewer)
- Explicit exclusions and non-intended uses

Use outside the stated scope is prohibited.

---

## 6. Hazard Identification

Potential hazards must be identified, including:
- False reassurance
- Missed risk signals
- Bias amplification
- Data drift
- Misinterpretation by users
- Over-reliance on AI outputs

Hazards must be documented prior to deployment.

---

## 7. Risk Assessment & Controls

For each identified hazard:
- Severity and likelihood are assessed
- Mitigation controls are defined
- Residual risk is evaluated

Controls may include:
- Confidence thresholds
- Alert suppression
- Human review mandates
- Usage restrictions

Uncontrolled risks block deployment.

---

## 8. Evidence Requirements

The safety case must reference verifiable evidence, including:
- Validation and testing results
- Calibration analyses
- Bias and fairness assessments
- Explainability artifacts
- Human override statistics
- System health and integrity records

Evidence must be versioned and traceable.

---

## 9. Human Oversight Integration

The safety case must demonstrate:
- Where human review is mandatory
- How disagreements are logged
- How overrides influence governance
- How accountability is preserved

Human authority is the primary safety control.

---

## 10. Operational Monitoring

The safety case must define:
- Safety performance indicators
- Drift and degradation signals
- Incident detection mechanisms
- Escalation pathways

Monitoring is continuous, not periodic.

---

## 11. Change Management

Any of the following require safety case review:
- Model retraining
- Threshold changes
- Data source changes
- Deployment context changes

Material changes invalidate prior approval.

---

## 12. Governance Approval

Safety cases are:
- Reviewed by domain experts
- Validated by compliance functions
- Approved through DAO governance where applicable
- Recorded immutably

Approval authority may not be delegated to model developers alone.

---

## 13. Post-Market Surveillance

The safety case remains active during operation and:
- Is updated with new evidence
- Incorporates incident findings
- May trigger model suspension or retirement

Safety justification is continuous.

---

## 14. Audit & Regulatory Access

Safety cases:
- Are retained indefinitely
- Are accessible to regulators and auditors
- Support inspection, challenge, and verification

Lack of transparency constitutes non-compliance.

---

## 15. Regulatory Alignment

This safety case aligns with:
- FDA GMLP safety assurance expectations
- EU AI Act risk management and documentation requirements
- ISO 14971 risk management
- IEC 62304 lifecycle safety principles
- WHO AI safety governance guidance

---

## 16. Ethical Position

> **A model without a safety case is an experiment on patients.  
> A safety case without evidence is fiction.**

Safety must be argued, proven, and maintained.

---

### Status
**Active – Clinical AI Safety Assurance Instrument**

